Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Offidani

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2020
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in ItalyM Talamonti, M Galluzzo, A Chiricozzi, et al.
The Journal of Dermatological Treatment|October 25, 2019
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitisM C Fargnoli, M Esposito, S Ferrucci, et al.
The Journal of Dermatological Treatment|May 22, 2020
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitisM C Fargnoli, M Esposito, S Ferrucci, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER studyC Bonifati, S Lembo, A G Richetta, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2020
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in ItalyM Talamonti, M Galluzzo, A Chiricozzi, et al.
The Journal of Dermatological Treatment|October 25, 2019
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitisM C Fargnoli, M Esposito, S Ferrucci, et al.
The Journal of Dermatological Treatment|May 22, 2020
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitisM C Fargnoli, M Esposito, S Ferrucci, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER studyC Bonifati, S Lembo, A G Richetta, et al.
Pageof 12